Wednesday, October 26, 2022 11:35:07 AM
Maker of Venom-Based Remedy Violated Securities Laws, Court Says
Sept. 1, 2022, 5:05 PM
Company allegedly raised money for cobra farm
CEO gets jury trial on claims he abetted violations
The SEC has proven that Nutra Pharma Corp. offered common stock without registering to do so or filing necessary forms, and that the CEO of the homeopathic remedy maker failed to report acquisitions of the stock as required, a federal court in New York ruled.
Summary judgment is appropriate on those claims, Judge Joanna Seybert said Wednesday for the US District Court for the Eastern District of New York.
But the Security and Exchange Commission’s claim that the executive, Erik Deitsch, aided and abetted securities law violations must be tried by a jury, she said.
https://news.bloomberglaw.com/litigation/maker-of-venom-based-remedy-violated-securities-laws-court-says
Buying quality stocks is the best get-rich-slow scheme. It’s not sexy as a get-rich-quick scheme,
but the probabilities of success are greater.
Remember........ It's better to wish you had bought a
stock, than to wish you hadn't.
FEATURED Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM
North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM
One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM
Element79 Gold Corp Announces 2024 Clover Work Plans & Nevada Portfolio Updates • ELMGF • Sep 10, 2024 11:00 AM